Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Gynecologic Oncology|May 29, 2016
Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancerShitanshu Uppal, Marcela G Del Carmen, Laurel W Rice, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 20, 2024
Small bite fascial closure technique reduces incisional hernia rates in gynecologic oncology patientsAlli M Straubhar, Cynthia Stroup, Amanda Manorot, et al.International Journal of Particle Therapy|February 25, 2026
Universal Fiducial Markers for Multi-Modal RadiotherapyJie Liu, Caroline Bamberger, Naveed Iqbal, et al.Gynecologic Oncology|October 13, 2023
Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancerHannah D McLaughlin, Patricia Greco, Alli M Straubhar, et al.Gynecologic Oncology|January 30, 2023
Provider compliance with a tailored opioid prescribing calculator in gynecologic surgeryAlli M Straubhar, Cynthia Stroup, Olivia de Bear, et al.Gynecologic Oncology|July 6, 2021
Optimization of postoperative opioid prescriptions in gynecologic oncology: Striking a balance between opioid reduction and pain controlAlli M Straubhar, Liam Dalton, Aimee Rolston, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Avoidable admissions after minimally invasive hysterectomyAmanda Manorot, Shitanshu Uppal, Olivia de Bear, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 9, 2024
Avoidable admissions after minimally invasive hysterectomyAmanda Manorot, Shitanshu Uppal, Olivia de Bear, et al.Bioorganic & Medicinal Chemistry|June 6, 2008
Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillin-resistant Staphylococcus aureus and Bacillus anthracisEdward Turos, Kevin D Revell, Praveen Ramaraju, et al.Journal of Translational Medicine|June 24, 2009
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancerHeather L Pulaski, Gregory Spahlinger, Ines A Silva, et al.Pageof 7